Biologic markers of chronic GVHD may provide insight into the pathogenesis of the
syndrome, identify molecular targets for novel interventions, and facilitate advances in …

Biology-based markers to confirm or aid in the diagnosis or prognosis of chronic graft-versus-
host disease (GVHD) after allogeneic hematopoietic cell transplantation or monitor its …

Decidual stromal cells (DSCs) isolated from fetal membranes of term placentas are easily
expanded and are highly immunosuppressive in vitro. These cells express high levels of …

Chronic graft-versus-host disease (cGVHD) is a leading cause of allogeneic hematopoietic
stem-cell transplantation-related mortality and morbidity. It is an immune-mediated disorder …

We have recently shown that lymphocyte and monocyte recovery by day+ 100 are
associated with survival post myeloablative allogeneic hematopoietic transplant for acute …

Chronic GVHD (cGVHD) is the major cause of long-term morbidity after allogeneic
hematopoietic stem cell transplantation (HSCT). There are no biomarkers that can …

Chronic graft versus host disease (cGvHD) is the main cause of long-term morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (HSCT)[1]. Several …

Aberrant innate and adaptive immune responsed to allergens and environmental pollutants
lead to respiratory allergic disease such as asthma. In this study, we focused on toll‐like …

Introduction: Chronic graft-versus-host disease (cGVHD) continues to be the leading cause
of late morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo …

Introduction Graft-versus-host disease (GvHD) remains a significant complication after
allogeneic hematopoietic stem cell transplantation (HSCT). Early diagnosis and treatment …